Story perspectives

Blood Biomarkers Diagnose Early-Onset Dementia, Predict Progression

6/17/2026

Summary

Story summary

The Korea Disease Control and Prevention Agency’s National Institute of Health announced that blood biomarkers can diagnose early-onset dementia and forecast its progression.
Professor Kim Eun-ju of Pusan National University Hospital led a two-year study of 322 patients under 65, including 245 with early-onset Alzheimer’s and 77 with frontotemporal dementia.
In early-onset Alzheimer’s, all key biomarker levels rose, with higher concentrations linked to faster cognitive decline.

1 of 1

Story summary

The Korea Disease Control and Prevention Agency’s National Institute of Health announced that blood biomarkers can diagnose early-onset dementia and forecast its progression.
Professor Kim Eun-ju of Pusan National University Hospital led a two-year study of 322 patients under 65, including 245 with early-onset Alzheimer’s and 77 with frontotemporal dementia.
In early-onset Alzheimer’s, all key biomarker levels rose, with higher concentrations linked to faster cognitive decline.